Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soterix Medical’s non-invasive neuromodulation platforms are used in hundreds of medical centers worldwide. Their HD-tDCS and LTE-tDCS technologies are under investigation in multiple clinical trials across a range of neuropsychiatric and neurological indications. The company has received FDA clearance for its MEGA-IOM intraoperative neuromonitoring device and holds multiple international regulatory approvals for its technologies. Clinical results indicate safety and usability with ongoing studies to establish efficacy across several conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soterix Medical.